{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T14:21:58Z","timestamp":1791382918412,"version":"4.3.3"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:00:00Z","timestamp":1734393600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences and Health Services","doi-asserted-by":"publisher","award":["70490-427-4-1402"],"award-info":[{"award-number":["70490-427-4-1402"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Retrovirology"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Human T-cell Lymphotropic Virus type-1 (HTLV-1) infection is associated with serious disorders, including Adult T-cell Leukemia\/Lymphoma (ATLL) and HTLV-1\u2013associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). In addition to sexual, vertical, parenteral, and blood transfusion, organ\/tissue transplantation is considered as a transmission route of HTLV infection. Given the substantial risk of HTLV-1 transmission and the subsequent development of HAM\/TSP (approximately 40%) in kidney transplant recipients, pre-transplant donor screening is crucial. The present study aimed to investigate the prevalence of HTLV-1 in potential organ\/tissue donors referred to the Iranian Tissue Bank and Research Center (ITBRC).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>The study population was potential organ and\/or tissue donors referred to ITBRC between 2014 and 2021, including two groups of brain death (potential donors of organs and\/or tissues) and circulatory death donors (potential tissue donors from Iranian Legal Medicine Organization). Initial screening was performed using enzyme-linked immunosorbent assay (ELISA), and positive cases were confirmed for HTLV-1 infection with polymerase chain reaction (PCR).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      111 out of 3,814 donors were positive for HTLV-1 (3%). The rate of positive tests between 2014 and 2017 was 6%, which was significantly higher than the positive tests percentage between 2017 and 2021 with 0.5% (\n                      <jats:italic>P<\/jats:italic>\n                      -value\u2009&lt;\u20090.001). The rate of test positivity in females was 4% compared to 2% in males (\n                      <jats:italic>P<\/jats:italic>\n                      -value\u2009=\u20090.001). Furthermore, individuals diagnosed with brain death exhibited a significantly lower likelihood of HTLV-1 infection (0.2%) compared to cases with circulatory death (4%) (\n                      <jats:italic>P<\/jats:italic>\n                      -value\u2009&lt;\u20090.001).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Considering the contraindication of organ\/tissue donation from donors with HTLV-1 positive test, these findings give an insight into the prevalence of HTLV-1 among potential organ\/tissue donors in Iran. Moreover, the higher prevalence of HTLV-1 infection in circulatory death donors from Iranian Legal Medicine Organization urges for cautious evaluation in these donors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12977-024-00656-9","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T04:39:29Z","timestamp":1734410369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Declining trend of HTLV-1 among organ\/ tissue donors in Iranian Tissue Bank between 2014\u20132021"],"prefix":"10.1186","volume":"21","author":[{"given":"Arash","family":"Letafati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayed Hamidreza","family":"Mozhgani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehdi","family":"Norouzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Aboofazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahra","family":"Taghiabadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Negar","family":"Zafarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Seyedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elnaz Mohammad","family":"Jaberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sedigheh","family":"Poursaleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Karami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheida","family":"Sarrafzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmadreza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,17]]},"reference":[{"key":"656_CR1","doi-asserted-by":"crossref","unstructured":"Mahdifar M, Boostani R, Taylor GP, Rezaee SA, Rafatpanah H. Comprehensive insight into the functional roles of NK and NKT Cells in HTLV-1-Associated diseases and Asymptomatic Carriers. Mol Neurobiol. 2024 Mar 4:1\u201313.","DOI":"10.1007\/s12035-024-03999-8"},{"key":"656_CR2","doi-asserted-by":"publisher","first-page":"1298308","DOI":"10.3389\/fpubh.2024.1298308","volume":"12","author":"N Ramesh","year":"2024","unstructured":"Ramesh N, Cockbain B, Taylor GP, Rosadas C. How do socioeconomic determinants of health affect the likelihood of living with HTLV-1 globally? A systematic review with meta-analysis. Front Public Health. 2024;12:1298308.","journal-title":"Front Public Health"},{"issue":"1","key":"656_CR3","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1111\/cas.15997","volume":"115","author":"A Yamada","year":"2024","unstructured":"Yamada A, Yasunaga Ji, Liang L, Zhang W, Sunagawa J, Nakaoka S, et al. Anti-HTLV\u20101 immunity combined with proviral load as predictive biomarkers for adult T\u2010cell leukemia\u2010lymphoma. Cancer Sci. 2024;115(1):310\u201320.","journal-title":"Cancer Sci"},{"issue":"11","key":"656_CR4","doi-asserted-by":"publisher","first-page":"e0225596","DOI":"10.1371\/journal.pone.0225596","volume":"14","author":"MV Pineda","year":"2019","unstructured":"Pineda MV, Bouzas MB, Remesar M, Fridman A, Remondegui C, Mammana L, et al. Relevance of HTLV-1 proviral load in asymptomatic and symptomatic patients living in endemic and non-endemic areas of Argentina. PLoS ONE. 2019;14(11):e0225596.","journal-title":"PLoS ONE"},{"issue":"1","key":"656_CR5","doi-asserted-by":"publisher","first-page":"e28424","DOI":"10.1002\/jmv.28424","volume":"95","author":"X Zuo","year":"2023","unstructured":"Zuo X, Zhou R, Yang S, Ma G. HTLV-1 persistent infection and ATLL oncogenesis. J Med Virol. 2023;95(1):e28424.","journal-title":"J Med Virol"},{"issue":"3","key":"656_CR6","doi-asserted-by":"publisher","first-page":"646","DOI":"10.3390\/cancers16030646","volume":"16","author":"J Chai","year":"2024","unstructured":"Chai J, Choudhuri J, Gong JZ, Wang Y, Tian X. Upregulation of enhancer of Zeste Homolog 2 (EZH2) with Associated pERK Co-expression and PRC2 complex protein SUZ12 correlation in adult T-Cell Leukemia\/Lymphoma. Cancers. 2024;16(3):646.","journal-title":"Cancers"},{"issue":"19","key":"656_CR7","first-page":"2299","volume":"141","author":"CR Bangham","year":"2023","unstructured":"Bangham CR. HTLV-1 persistence and the oncogenesis of adult T-cell leukemia\/lymphoma. Blood. J Am Soc Hematol. 2023;141(19):2299\u2013306.","journal-title":"J Am Soc Hematol"},{"key":"656_CR8","doi-asserted-by":"publisher","first-page":"107669","DOI":"10.1016\/j.pharmthera.2020.107669","volume":"218","author":"J Yamauchi","year":"2021","unstructured":"Yamauchi J, Araya N, Yagishita N, Sato T, Yamano Y. An update on human T-cell leukemia virus type I (HTLV-1)-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) focusing on clinical and laboratory biomarkers. Pharmacol Ther. 2021;218:107669.","journal-title":"Pharmacol Ther"},{"issue":"7","key":"656_CR9","doi-asserted-by":"publisher","first-page":"3839","DOI":"10.1007\/s12035-023-03303-0","volume":"60","author":"M Shafiei","year":"2023","unstructured":"Shafiei M, Mozhgani S-H. Th17\/IL-17 Axis in HTLV-1-associated myelopathy tropical spastic paraparesis and multiple sclerosis: novel insights into the immunity during HAMTSP. Mol Neurobiol. 2023;60(7):3839\u201354.","journal-title":"Mol Neurobiol"},{"issue":"11","key":"656_CR10","first-page":"1096","volume":"3","author":"JE Kaplan","year":"1990","unstructured":"Kaplan JE, Osame M, Kubota H, Igata A, Nishitani H, Maeda Y, et al. The risk of development of HTLV-I-associated myelopathy\/tropical spastic paraparesis among persons infected with HTLV-I. JAIDS J Acquir Immune Defic Syndr. 1990;3(11):1096\u2013101.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"2","key":"656_CR11","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1097\/00042560-199802010-00011","volume":"17","author":"EM Maloney","year":"1998","unstructured":"Maloney EM, Cleghorn FR, Morgan OSC, Rodgers-Johnson P, Cranston B, Jack N, et al. Incidence of HTLV-I-associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in Jamaica and Trinidad. JAIDS J Acquir Immune Defic Syndr. 1998;17(2):167\u201370.","journal-title":"JAIDS J Acquir Immune Defic Syndr"},{"issue":"6","key":"656_CR12","first-page":"428","volume":"13","author":"R Boostani","year":"2011","unstructured":"Boostani R, Ardakani AM, Ashrafi H. Khorasan disease: prevalence of HTLV-I associated myelopathy\/tropical spastic paraparesis (HAM\/TSP) in West Azarbaijan from 2004 to 2007. Iran Red Crescent Med J. 2011;13(6):428.","journal-title":"Iran Red Crescent Med J"},{"key":"656_CR13","unstructured":"Gessain A, Cassar O. Geographical distribution of areas with a high prevalence of HTLV-1 infection. ECDC; 2015."},{"issue":"1","key":"656_CR14","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S1473-3099(19)30402-5","volume":"20","author":"G Schierhout","year":"2020","unstructured":"Schierhout G, McGregor S, Gessain A, Einsiedel L, Martinello M, Kaldor J. Association between HTLV-1 infection and adverse health outcomes: a systematic review and meta-analysis of epidemiological studies. Lancet Infect Dis. 2020;20(1):133\u201343.","journal-title":"Lancet Infect Dis"},{"key":"656_CR15","doi-asserted-by":"publisher","first-page":"840295","DOI":"10.3389\/fpubh.2022.840295","volume":"10","author":"M Martel","year":"2022","unstructured":"Martel M, Gotuzzo E. HTLV-1 is also a sexually transmitted infection. Front Public Health. 2022;10:840295.","journal-title":"Front Public Health"},{"issue":"6","key":"656_CR16","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1007\/s13365-020-00910-8","volume":"26","author":"MR Hedayati-Moghaddam","year":"2020","unstructured":"Hedayati-Moghaddam MR, Mollahosseini F, Namazi MJ, Mosavat A, Rezaee SA, Mahdifar M, et al. Status of humoral and cellular immune markers in human T-cell lymphotropic virus type 1 (HTLV-1) asymptomatic carriers in northeastern Iran, Mashhad. J Neurovirol. 2020;26(6):863\u20139.","journal-title":"J Neurovirol"},{"key":"656_CR17","doi-asserted-by":"publisher","first-page":"e2020605","DOI":"10.1590\/0037-8682-605-2020","volume":"54","author":"C Rosadas","year":"2021","unstructured":"Rosadas C, Brites C, Arakaki-Sanchez D, Casseb J, Ishak R. Brazilian protocol for sexually transmitted infections 2020: human T-cell lymphotropic virus (HTLV) infection. Rev Soc Bras Med Trop. 2021;54:e2020605.","journal-title":"Rev Soc Bras Med Trop"},{"issue":"1","key":"656_CR18","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1093\/cid\/ciu227","volume":"59","author":"S Hewagama","year":"2014","unstructured":"Hewagama S, Krishnaswamy S, King L, Davis J, Baird R. Human T-Cell lymphotropic virus type 1 exposures following blood-borne virus incidents in Central Australia, 2002\u20132012. Clin Infect Dis. 2014;59(1):85\u20137.","journal-title":"Clin Infect Dis"},{"key":"656_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-019-4346-z","volume":"19","author":"C de Mendoza","year":"2019","unstructured":"de Mendoza C, Roc L, Benito R, Reina G, Ramos JM, G\u00f3mez C, et al. HTLV-1 infection in solid organ transplant donors and recipients in Spain. BMC Infect Dis. 2019;19:1\u20135.","journal-title":"BMC Infect Dis"},{"key":"656_CR20","doi-asserted-by":"publisher","first-page":"105619","DOI":"10.1016\/j.jcv.2023.105619","volume":"169","author":"C de-Mendoza","year":"2023","unstructured":"de-Mendoza C, P\u00e9rez L, Rando A, Reina G, Aguilera A, Benito R, et al. HTLV-1-associated myelopathy in Spain. J Clin Virol. 2023;169:105619.","journal-title":"J Clin Virol"},{"issue":"3","key":"656_CR21","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1056\/NEJMc1809779","volume":"380","author":"J Yamauchi","year":"2019","unstructured":"Yamauchi J, Yamano Y, Yuzawa K. Risk of human T-cell leukemia virus type 1 infection in kidney transplantation. N Engl J Med. 2019;380(3):296\u20138.","journal-title":"N Engl J Med"},{"issue":"11","key":"656_CR22","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s12032-023-02177-5","volume":"40","author":"A Letafati","year":"2023","unstructured":"Letafati A, Mozhgani SH, Marjani A, Amiri A, Siami Z, Mohammaditabar M, et al. Decoding dysregulated angiogenesis in HTLV-1 asymptomatic carriers compared to healthy individuals. Med Oncol. 2023;40(11):317.","journal-title":"Med Oncol"},{"key":"656_CR23","doi-asserted-by":"publisher","first-page":"1043600","DOI":"10.3389\/fimmu.2023.1043600","volume":"14","author":"A Gessain","year":"2023","unstructured":"Gessain A, Ramassamy J-L, Afonso PV, Cassar O. Geographic distribution, clinical epidemiology and genetic diversity of the human oncogenic retrovirus HTLV-1 in Africa, the world\u2019s largest endemic area. Front Immunol. 2023;14:1043600.","journal-title":"Front Immunol"},{"key":"656_CR24","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-N\u00fa\u00f1ez J-P, de-Miguel-Balsa E, Soriano V, Lorenzo-Garrido E, Gim\u00e9nez-Richarte A, Otero-Rodriguez S et al. Prevalence of HTLV-1\/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta\u2013analysis. Int J Infect Dis. 2024 Mar 22:107018.","DOI":"10.1016\/j.ijid.2024.107018"},{"issue":"3","key":"656_CR25","doi-asserted-by":"publisher","first-page":"e28606","DOI":"10.1002\/jmv.28606","volume":"95","author":"M Satake","year":"2023","unstructured":"Satake M, Sagara Y, Hamaguchi I. Lower prevalence of anti-HTLV\u20101 as expected by previous models among first\u2010time blood donors in Japan. J Med Virol. 2023;95(3):e28606.","journal-title":"J Med Virol"},{"issue":"08","key":"656_CR26","doi-asserted-by":"publisher","first-page":"585","DOI":"10.2217\/fvl-2018-0015","volume":"13","author":"M Azami","year":"2018","unstructured":"Azami M, Badfar G, Esmaeli E, Moslemirad M, Rahmati S. Epidemiology of human T-lymphotropic virus type 1 among blood donors and general population in Iran: a meta-analysis. Future Virol. 2018;13(08):585\u201399.","journal-title":"Future Virol"},{"issue":"3","key":"656_CR27","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.jcv.2011.07.004","volume":"52","author":"H Rafatpanah","year":"2011","unstructured":"Rafatpanah H, Hedayati-Moghaddam MR, Fathimoghadam F, Bidkhori HR, Shamsian SK, Ahmadi S, et al. High prevalence of HTLV-I infection in Mashhad, Northeast Iran: a population-based seroepidemiology survey. J Clin Virol. 2011;52(3):172\u20136.","journal-title":"J Clin Virol"},{"issue":"1","key":"656_CR28","doi-asserted-by":"publisher","first-page":"57","DOI":"10.18869\/acadpub.ibj.21.1.57","volume":"21","author":"M Salehi","year":"2017","unstructured":"Salehi M, Mostafavi SKS, Ghasemian A, Gholami M, Kazemi-Vardanjani A, Rahimi MK. Seroepidemiology of HTLV-1 and HTLV-2 infection in Neyshabur city, North-Eastern Iran, during 2010\u20132014. Iran Biomed J. 2017;21(1):57.","journal-title":"Iran Biomed J"},{"issue":"7","key":"656_CR29","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1002\/jmv.24448","volume":"88","author":"H Rafatpanah","year":"2016","unstructured":"Rafatpanah H, Torkamani M, Valizadeh N, Vakili R, Meshkani B, Khademi H, et al. Prevalence and phylogenetic analysis of HTLV-1 in a segregated population in Iran. J Med Virol. 2016;88(7):1247\u201353.","journal-title":"J Med Virol"},{"issue":"2","key":"656_CR30","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11262-024-02051-0","volume":"60","author":"M Safavi","year":"2024","unstructured":"Safavi M, Habibian-Sezavar F, Letafati A, Solouki S, Yaslianifard S, Kaboli P, et al. Determination of molecular epidemiologic pattern of human T-lymphotropic virus type 1 (HTLV-1) in Alborz Province, Iran. Virus Genes. 2024;60(2):117\u201325.","journal-title":"Virus Genes"},{"key":"656_CR31","doi-asserted-by":"publisher","first-page":"114073","DOI":"10.1016\/j.jviromet.2021.114073","volume":"290","author":"HM Habibabadi","year":"2021","unstructured":"Habibabadi HM, Parsania M, Pourfathollah AA, Bahrami A, Sharifi Z. Prevalence and phylogenetic analysis of HTLV-1 in blood donors in Golestan Province, in the Northeast of Iran. J Virol Methods. 2021;290:114073.","journal-title":"J Virol Methods"},{"issue":"11","key":"656_CR32","first-page":"2136","volume":"49","author":"F Hatatian","year":"2020","unstructured":"Hatatian F, Babakhani F, Gudarzi H, Momenifar N, Norouzi M, Shafieifar M, et al. Relative frequency of blood-borne viruses in hemodialysis-dependent and kidney transplant recipients in Iran. Iran J Public Health. 2020;49(11):2136.","journal-title":"Iran J Public Health"},{"issue":"8","key":"656_CR33","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/jmv.25192","volume":"90","author":"L Pirayeshfard","year":"2018","unstructured":"Pirayeshfard L, Sharifi Z, Amini-Kafiabad S, Haghnazari Sadaghiani N. Phylogenetic analysis of HTLV\u20101 in Iranian blood donors, HIV\u20101 positive patients and patients with beta thalassemia. J Med Virol. 2018;90(8):1398\u2013405.","journal-title":"J Med Virol"},{"issue":"2","key":"656_CR34","first-page":"146","volume":"8","author":"ZR Khameneh","year":"2010","unstructured":"Khameneh ZR, Sepehrvand N, Masudi S, Taghizade-Afshari A. Seroprevalence of HTLV-1 among kidney graft recipients: a single-center study. Exp Clin Transpl. 2010;8(2):146\u20139.","journal-title":"Exp Clin Transpl"},{"issue":"4","key":"656_CR35","first-page":"14","volume":"46","author":"JA ARIAS-MURILLO YR, CORT\u00c9S-LUNA JA, C","year":"2021","unstructured":"ARIAS-MURILLO YR, CORT\u00c9S-LUNA JA, CHAC\u00d3N-SARMIENTO JA. Seroprevalence of HTLV-1 and 2 in organ donors and kidney transplant recipients. Colombia 2010\u20132017. Acta Med Colombiana. 2021;46(4):14\u20137.","journal-title":"Acta Med Colombiana"},{"issue":"6","key":"656_CR36","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1111\/j.1600-6143.2012.04037.x","volume":"12","author":"T Yoshizumi","year":"2012","unstructured":"Yoshizumi T, Shirabe K, Ikegami T, Kayashima H, Yamashita N, Morita K, et al. Impact of human T cell leukemia virus type 1 in living donor liver transplantation. Am J Transplant. 2012;12(6):1479\u201385.","journal-title":"Am J Transplant"},{"key":"656_CR37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12879-020-05405-9","volume":"20","author":"A Omidkhoda","year":"2020","unstructured":"Omidkhoda A, Razi B, Arabkhazaeli A, Amini Kafi-Abad S. Trends and epidemiological analysis of hepatitis B virus, hepatitis C virus, human immunodeficiency virus, and human T-cell lymphotropic virus among Iranian blood donors: strategies for improving blood safety. BMC Infect Dis. 2020;20:1\u201312.","journal-title":"BMC Infect Dis"},{"key":"656_CR38","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1007\/s10561-008-9117-9","volume":"10","author":"B Arjmand","year":"2009","unstructured":"Arjmand B, Aghayan SH, Goodarzi P, Farzanehkhah M, Mortazavi SM, Niknam MH, et al. Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank. Cell Tissue Banking. 2009;10:247\u201352.","journal-title":"Cell Tissue Banking"},{"key":"656_CR39","doi-asserted-by":"crossref","unstructured":"Nasri E, Fakhim H, Sales AJ, Baghi HB, Vaezi A, Rezaei M et al. Prevalence of human T-Lymphotropic virus type 1 in brain-dead organ donors. Archives Clin Infect Dis. 2022;17(1).","DOI":"10.5812\/archcid-116005"},{"key":"656_CR40","doi-asserted-by":"publisher","first-page":"204993611986802","DOI":"10.1177\/2049936119868028","volume":"6","author":"L Roc","year":"2019","unstructured":"Roc L, de Mendoza C, Fern\u00e1ndez-Alonso M, Reina G, Soriano V, Network SH. Rapid subacute myelopathy following kidney transplantation from HTLV-1 donors: role of immunosuppresors and failure of antiretrovirals. Therapeutic Adv Infect Disease. 2019;6:2049936119868028.","journal-title":"Therapeutic Adv Infect Disease"},{"issue":"7","key":"656_CR41","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1097\/QAD.0000000000002508","volume":"34","author":"J-M Ramos","year":"2020","unstructured":"Ramos J-M, de Mendoza C, Aguilera A, Barreiro P, Benito R, Eiros JM, et al. Hospital admissions in individuals with HTLV-1 infection in Spain. Aids. 2020;34(7):1019\u201327.","journal-title":"Aids"},{"issue":"1","key":"656_CR42","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/00007890-200301150-00019","volume":"75","author":"C Toro","year":"2003","unstructured":"Toro C, Rod\u00e9s B, Poveda E, Soriano V. Rapid development of subacute myelopathy in three organ transplant recipients after transmission of human T-cell lymphotropic virus type I from a single donor. Transplantation. 2003;75(1):102\u20134.","journal-title":"Transplantation"},{"issue":"1","key":"656_CR43","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s41100-023-00480-5","volume":"9","author":"N Kawano","year":"2023","unstructured":"Kawano N, Kyohei Y, Miyoshi H, Yoshida N, Ohshima K, Arakawa F, et al. The development of adult T cell leukemia\/lymphoma in renal transplant recipients: report of two cases with literature review. Ren Replace Therapy. 2023;9(1):36.","journal-title":"Ren Replace Therapy"},{"issue":"2","key":"656_CR44","doi-asserted-by":"publisher","first-page":"e1970","DOI":"10.1002\/rmv.1970","volume":"28","author":"GP Taylor","year":"2018","unstructured":"Taylor GP. Human T-lymphotropic virus type 1 infection and solid organ transplantation. Rev Med Virol. 2018;28(2):e1970.","journal-title":"Rev Med Virol"}],"container-title":["Retrovirology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-024-00656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12977-024-00656-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12977-024-00656-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T17:02:16Z","timestamp":1734454936000},"score":1,"resource":{"primary":{"URL":"https:\/\/retrovirology.biomedcentral.com\/articles\/10.1186\/s12977-024-00656-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,17]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["656"],"URL":"https:\/\/doi.org\/10.1186\/s12977-024-00656-9","relation":{},"ISSN":["1742-4690"],"issn-type":[{"value":"1742-4690","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,17]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical code has been obtained from Tehran University of Medical Sciences, Tehran, Iran (IR.TUMS.SPH.REC.1402.329).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"informed consent for publication of identifiable information\/ images in open access journal was obtained from all study participants or their legal guardians.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22"}}